26 results on '"Nobili, Valerio"'
Search Results
2. Clinical Course Of Infection With Hepatitis C: Is Still Poorly Understood
- Author
-
Vento, Sandro, Nobili, Valerio, and Cainelli, Francesca
- Published
- 2006
3. Plasma N‐terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non‐alcoholic fatty liver disease.
- Author
-
Mosca, Antonella, Comparcola, Donatella, Romito, Ilaria, Mantovani, Alessandro, Nobili, Valerio, Byrne, Christopher D., Alisi, Anna, and Targher, Giovanni
- Subjects
FATTY liver ,COLLAGEN ,RECEIVER operating characteristic curves ,BRAIN natriuretic factor ,FIBROSIS ,ENZYME-linked immunosorbent assay - Abstract
Background & Aims: We examined the diagnostic performance of plasma N‐terminal propeptide of type III procollagen (PIIINP) levels, aspartate aminotransferase to platelet ratio index (APRI) and Fibrosis‐4 (FIB‐4) score for predicting non‐alcoholic steatohepatitis (NASH) and liver fibrosis stage in children/adolescents with non‐alcoholic fatty liver disease (NAFLD). Methods: We enrolled 204 children/adolescents with biopsy‐proven NAFLD at the "Bambino Gesù" Children's Hospital. We measured plasma PIIINP levels using a commercially available enzyme‐linked immunosorbent assay kit and calculated APRI and FIB‐4 scores using standard methods. Results: Children with NASH had higher plasma PIIINP levels, APRI and FIB‐4 scores compared with those without NASH (all P < .001). However, PIIINP levels had much better diagnostic performance and accuracy than APRI and FIB‐4 scores for predicting liver fibrosis stage. PIIINP levels correlated with the total NAFLD activity score (NAS) and its constituent components (P < .0001). The risk of either NASH or F ≥ 2 fibrosis progressively increased with increasing PIIINP levels (P < .0001), independent of age, gender, adiposity measures, insulin resistance, NAS score and the patatin‐like phospholipase domain‐containing protein‐3 rs738409 polymorphism. For every 3.6 ng/mL increase in PIIINP levels, the likelihood of having F ≥ 2 fibrosis increased by ~14‐fold (adjusted‐odds ratio 14.1, 95% CI 5.50‐35.8, P < .0001) after adjustment for the aforementioned risk factors. The area under the receiver operating characteristics curve was 0.921 (95% CI 0.87‐0.97) for F ≥ 2 fibrosis, and 0.993 (95% CI 0.98‐1.0) for F3 fibrosis respectively. Conclusions: Unlike APRI and FIB‐4 scores, plasma PIIINP levels are a promising, non‐invasive biomarker for diagnosing liver fibrosis stage in children/adolescents with biopsy‐proven NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.
- Author
-
Alisi, Anna, Pampanini, Valentina, De Stefanis, Cristiano, Panera, Nadia, Deodati, Annalisa, Nobili, Valerio, and Cianfarani, Stefano
- Subjects
FATTY liver ,SOMATOMEDIN C ,PEDIATRICS ,IMMUNOFLUORESCENCE ,MESSENGER RNA - Abstract
Background and aims: Nonalcoholic fatty liver disease is one of the major complications of obesity, occurring already in pediatric age. Insulin like growth factor-I has been proposed as a potential therapeutic agent for its beneficial effect in experimental liver fibrosis. The aim of this work was to investigate the expression of insulin-like growth factor-I and its receptor in the liver of children with biopsy-proven nonalcoholic fatty liver disease and relate it to liver histological features. Methods: 45 obese children and adolescents (14 females and 31 males) with nonalcoholic fatty liver disease were included. Insulin like growth factor-I and its receptor expression was evaluated in liver tissue by immunofluorescence and qPCR. Results: The expression of insulin like growth factor-I and its receptor were significantly related to fibrosis and were higher in children with stage 3 fibrosis compared to stage 1 and 2 (p<0.001 and p = 0.007 respectively). mRNA of insulin like growth factor-I receptor was higher in more advanced stages of fibrosis (p<0.001). Furthermore, the expression of insulin like growth factor-I and its receptor in hepatic stellate cells, the cell type mostly involved in fibrosis progression, was significantly increased in stage 3 fibrosis compared to stage 1 (p = 0.01 and p = 0.008 respectively). Conclusions: We demonstrated for the first time that insulin like growth factor-I and its receptor are upregulated in children with nonalcoholic fatty liver disease. These findings give a new hint for the potential therapeutic use of insulin like growth factor-I in pediatric nonalcoholic fatty liver disease complicated by liver fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life.
- Author
-
Deodati, Annalisa, Argemí, Josepmaría, Germani, Daniela, Puglianiello, Antonella, Alisi, Anna, De Stefanis, Cristiano, Ferrero, Roberto, Nobili, Valerio, Aragón, Tomás, and Cianfarani, Stefano
- Subjects
CHRONIC diseases ,ENDOPLASMIC reticulum ,FETAL development ,MESSENGER RNA ,GLUCONEOGENESIS - Abstract
Early life events are associated with the susceptibility to chronic diseases in adult life. Perturbations of endoplasmic reticulum (ER) homeostasis activate the unfolded protein response (UPR), which contributes to the development of metabolic alterations. Our aim was to evaluate liver UPR in an animal model of intrauterine growth restriction (IUGR). A significantly increased expression of X-box binding protein-1 spliced (XBP1s) mRNA (p<0.01), Endoplasmic Reticulum-localized DnaJ homologue (Erdj4) mRNA (p<0.05) and Bip/GRP78-glucose-regulated protein 78 (Bip) mRNA (p<0.05) was observed in the liver of IUGR rats at birth. Furthermore, the expression of gluconeogenesis genes and lipogenesis genes were significantly upregulated (p<0.05) in IUGR pups. At 105 d, IUGR male rats showed significantly reduced glucose tolerance (p<0.01). A significant decreased expression of XBP1s mRNA (p<0.01) and increased expression of double-stranded RNA-dependent protein kinase-like ER kinase (PERK) and Asparagine synthetase (ASNS) (p<0.05) was observed in the liver of IUGR male adult rats. Liver focal steatosis and periportal fibrosis were observed in IUGR rats. These findings show for the first time that fetal exposure to uteroplacental insufficiency is associated with the activation of hepatic UPR and suggest that UPR signaling may play a role in the metabolic risk. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
6. Liver zonation in children with non‐alcoholic fatty liver disease: Associations with dietary fructose and uric acid concentrations.
- Author
-
Nobili, Valerio, Mosca, Antonella, De Vito, Rita, Raponi, Massimiliano, Scorletti, Eleonora, and Byrne, Christopher D.
- Subjects
- *
LIVER injuries , *HYPERURICEMIA , *FRUCTOSE , *FIBROSIS , *FATTY liver - Abstract
Abstract: Background & Aims: As dietary components are delivered directly to the periportal zone of the liver lobule, there is the potential for greater injury in this zone (zone 1) compared to the perivenous zone (zone 3). We investigated the associations between dietary fructose consumption and uric acid concentrations and differential zonal injury in periportal and perivenous zones. Methods: A total of 271 children's histological images were scored in 5 periportal and 5 perivenous zones for steatosis, ballooning, inflammation and fibrosis severity. Dietary fructose consumption (g/d) was assessed and uric acid measured in serum. Logistic regression was undertaken to test associations between both high fructose consumption and hyperuricaemia, and histological disease in periportal and perivenous zones. Results: Children with a mean age of 12.5 years were included in the study. Inflammation (mean ± SD) was increased in the periportal vs perivenous zones (0.78 ± 0.43 vs 0.41 ± 0.48, P = .041). There were non‐significant trends towards greater steatosis, ballooning and fibrosis in the periportal zone. In the fully adjusted models, high fructose intake was associated with disease in both zones. Example for periportal and perivenous zones, respectively, steatosis 1.56 (1.12, 2.49) and 1.21 (1.09, 2.73); inflammation 4.29 (2.31, 5.88) and 3.69 (2.14, 4.56); and fibrosis 2.72 (1.43, 3.76) and 1.96 (1.24, 2.37). Hyperuricaemia (uric acid ≥5.9 mg/dL) was associated with inflammation in the periportal zone 1.71 (1.17, 2.35); and was associated with steatosis and fibrosis in both zones; for example, for periportal and perivenous zones, respectively, steatosis 2.98 (1.65, 3.23) and 1.14 (1.05, 1.99); and fibrosis, 2.65 (1.35, 2.99) and 1.31 (1.13, 2.17). Conclusions: High fructose consumption is associated with disease severity in both lobular zones and hyperuricaemia may be associated with more severe disease in the periportal zone. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
7. Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.
- Author
-
Della Corte, Claudia, Carpino, Guido, De Vito, Rita, De Stefanis, Cristiano, Alisi, Anna, Cianfarani, Stefano, Overi, Diletta, Mosca, Antonella, Stronati, Laura, Cucchiara, Salvatore, Raponi, Massimiliano, Gaudio, Eugenio, Byrne, Christopher D., and Nobili, Valerio
- Subjects
VITAMIN D deficiency ,VITAMIN deficiency ,FATTY liver ,THERAPEUTICS ,THERAPEUTIC use of vitamin D ,JUVENILE diseases ,DIAGNOSIS - Abstract
Background: There are no licensed treatments for non alcoholic fatty liver disease (NAFLD) in adults or children. In NAFLD, several studies have shown a benefit of omega-3 fatty acid treatment on lipid profile, insulin-sensitivity and hepatic steatosis and it has also been suggested that Vitamin D treatment has potential antifibrotic properties in liver disease. Trial Design: To date, however, there are no studies that have tested the combination of Docosahexanoic acid (DHA) and vitamin D treatment which may benefit the whole spectrum of disease in NAFLD. Our aim therefore, was to test the effect of daily DHA (500 mg) plus vitamin D (800 IU) treatment, in obese children with biopsy-proven NAFLD and vitamin D deficiency, in a randomized, double-blind placebo-controlled trial. Methods: The 41/43 patients completed the study (18-treatment, 23-placebo). At 12 months: i) the main outcome was liver histology improvement, defined by NAS; ii) the secondary outcome was amelioration of metabolic parameters. Results: DHA plus vitamin D treatment reduced the NAFLD Activity Score (NAS), in the treatment group (5.4 v1.92; p<0.001 for baseline versus end of study). There was no change in fibrosis score, but a reduction of the activation of hepatic stellate cells (HSC) and fibrillar collagen content was noted (3.51±1.66 v. 1.59±1.37; p = 0.003) in treatment group. Moreover, the triglycerides (174.5 vs. 102.15 mg/dl), ALT (40.25 vs. 24.5 UI/l) and HOMA-IR (4.59 vs. 3.42) were all decreased with treatment. Conclusion: DHA plus vitamin D treatment improved insulin-resistance, lipid profile, ALT and NAS. There was also decreased HSC activation and collagen content with treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
8. Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.
- Author
-
Carpino, Guido, Nobili, Valerio, Renzi, Anastasia, De Stefanis, Cristiano, Stronati, Laura, Franchitto, Antonio, Alisi, Anna, Onori, Paolo, De Vito, Rita, Alpini, Gianfranco, and Gaudio, Eugenio
- Subjects
- *
MACROPHAGE activation , *LIVER diseases , *PROGENITOR cells , *JUVENILE diseases , *DOCOSAHEXAENOIC acid - Abstract
Non-alcoholic fatty liver disease is one of the most important causes of liver-related morbidity in children. In non-alcoholic fatty liver disease, the activation of liver resident macrophage pool is a central event in the progression of liver injury. The aims of the present study were to evaluate the polarization of liver macrophages and the possible role of Wnt3a production by macrophages in hepatic progenitor cell response in the progression of pediatric non-alcoholic fatty liver disease. 32 children with biopsy-proven non-alcoholic fatty liver disease were included. 20 out of 32 patients were treated with docosahexaenoic acid for 18 months and biopsies at the baseline and after 18 months were included. Hepatic progenitor cell activation, macrophage subsets and Wnt/β-catenin pathway were evaluated by immunohistochemistry and immunofluorescence. Our results indicated that in pediatric non-alcoholic fatty liver disease, pro-inflammatory macrophages were the predominant subset. Macrophage polarization was correlated with Non-alcoholic fatty liver disease Activity Score, ductular reaction, and portal fibrosis; docosahexaenoic acid treatment determined a macrophage polarization towards an anti-inflammatory phenotype in correlation with the reduction of serum inflammatory cytokines, with increased macrophage apoptosis, and with the up-regulation of macrophage Wnt3a expression; macrophage Wnt3a expression was correlated with β-catenin phosphorylation in hepatic progenitor cells and signs of commitment towards hepatocyte fate. In conclusion, macrophage polarization seems to have a key role in the progression of pediatric non-alcoholic fatty liver disease; the modulation of macrophage polarization could drive hepatic progenitor cell response by Wnt3a production. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
9. Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease.
- Author
-
Tabbaa, Adam, Shaker, Mina, Lopez, Rocio, Hoshemand, Kazem, Nobili, Valerio, and Alkhouri, Naim
- Subjects
LOW-potassium diet ,FATTY liver ,METABOLIC disorders in children ,NUTRITION - Abstract
Purpose: Recent studies have suggested that decreased serum potassium level may contribute to various metabolic disorders in adult patients including nonalcoholic fatty liver disease (NAFLD). We aimed to study the correlation between serum potassium levels and the histologic severity of NAFLD in children. Methods: Pediatric patients with biopsy-proven NAFLD were included in this study. Demographic, clinical, and histopathological data were obtained. Multivariable logistic regression analysis was used to assess whether potassium levels are associated with the presence of nonalcoholic steatohepatitis (NASH) or fibrosis after adjusting for possible confounders. A p-value <0.05 was considered statistically significant. Results: Among 125 biopsies, 49.6% (62) had evidence of NASH while 66.4% (83) had some degree of fibrosis (stage 1-3). Mean serum potassium was significantly lower in NASH group as compared to non-NASH group (4.4±0.42 mmoL/L vs. 4.8±0.21, p<0.001). Higher potassium level had negative correlation with presence of steatosis, ballooning, lobular inflammation, fibrosis and NAFLD activity score (p<0.05). On multivariable analysis and after adjusting for the metabolic syndrome and insulin resistance, higher potassium level was significantly associated with lower likelihood of having a histological diagnosis of NASH on biopsy (odds ratio [OR], 0.12; 95% confidence interval [95% CI], 0.05-0.28; p<0.001). Similarly, the likelihood of having fibrosis decreases by 76% for every 0.5 mmoL/L increase in potassium (OR, 0.24; 95% CI, 0.11-0.54; p<0.001). Conclusion: Our study shows an inverse relationship between serum potassium levels and the presence of aggressive disease (NASH and fibrosis) in children with NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease.
- Author
-
Alkhouri, Naim, Mansoor, Sana, Giammaria, Paola, Liccardo, Daniela, Lopez, Rocio, and Nobili, Valerio
- Subjects
JUVENILE diseases ,PEDIATRICS ,GASTROENTEROLOGY ,FATTY liver ,CIRRHOSIS of the liver ,FIBROSIS ,CHRONIC diseases - Abstract
Background: Noninvasive hepatic fibrosis scores that predict the presence of advanced fibrosis have been developed and validated in adult patients with NAFLD. The aims of our study were to assess the utility of commonly used adult fibrosis scores in pediatric NAFLD and to develop a pediatric specific fibrosis score that can predict advanced fibrosis. Methods: Consecutive children with biopsy-proven NAFLD were included. Fibrosis was determined by an experienced pathologist (F0–4). Advanced fibrosis was defined as fibrosis stage ≥3. The following adult fibrosis scores were calculated for each child: AST/ALT ratio, AST/platelet ratio index (APRI), NAFLD fibrosis score (NFS), and FIB-4 Index. Multivariable logistic regression analysis was performed to build a new pediatric model for predicting advanced fibrosis. Results: Our cohort consisted of 242 children with a mean age of 12.4±3.1 years and 63% were female. 36 (15%) subjects had advanced fibrosis. APRI and FIB-4 were higher in patients with advanced fibrosis compared to those with fibrosis stage 0–2; however, AST/ALT ratio and NFS were not different between the two groups. We used our data to develop a new model to predict advanced fibrosis which included: ALT, alkaline phosphatase, platelet counts and GGT. The multivariable logistic regression model (z) was defined as follows: z = 1.1+(0.34*sqrt(ALT))+(0.002*alkaline phosphatase) – (1.1*log(platelets) – (0.02*GGT). This value was then converted into a probability distribution (p) with a value between 0 to 100 by the following formula: p = 100×exp(z)/[1+exp(z)]. The AUCROC for this model was 0.74 (95% CI: 0.66, 0.82). This was found to be significantly better than APRI, NAFLD Fibrosis Score and FIB-4 Index. Conclusion: Noninvasive hepatic fibrosis scores developed in adults had poor performance in diagnosing advanced fibrosis in children with NAFLD. We developed a new pediatric NAFLD fibrosis score with improved performance characteristics. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
11. Macrophages and fibrosis in adipose tissue are linked to liver damage and metabolic risk in obese children.
- Author
-
Walker, Ryan W., Allayee, Hooman, Inserra, Alessandro, Fruhwirth, Rodolfo, Alisi, Anna, Devito, Rita, Carey, Magalie E., Sinatra, Frank, Goran, Michael I., and Nobili, Valerio
- Subjects
MACROPHAGES ,ADIPOSE tissues ,FIBROSIS ,LIVER diseases ,CHILDHOOD obesity - Abstract
Objective Obesity in childhood is associated with an inflammatory state in adipose tissue and liver, which elevates risk for diabetes and liver disease. No prior study has examined associations between pathologies occurring in adipose tissue and liver to identify elements of tissue damage associated with type 2 diabetes risk. This study sought to determine whether inflammation and fibrosis in abdominal subcutaneous adipose tissue (SAT) in obese/overweight children (BMI- z 2.3 ± 0.76) was related to the extent of observed liver disease or type 2 diabetes risk. Methods Biopsy samples of abdominal (SAT) and liver were simultaneously collected from 33 Italian children (mean BMI 28.1 ± 5.1 kg/m
2 and mean age 11.6 ± 2.2 years) with confirmed NAFLD. Histology and immunohistochemistry were conducted on biopsies to assess inflammation and fibrosis in adipose tissue and fibrosis and inflammation in liver. Results Presence vs. absence of crown-like structures (CLS) in SAT was significantly related to liver fibrosis scores (1.7 ± 0.7 vs. 1.2 ± 0.7, P = 0.04) independent of BMI. SAT fibrosis was significantly correlated with a lower disposition index ( r = −0.48, P = 0.006). No other adipose measures were associated with liver disease parameters. Conclusion Markers of subcutaneous white adipose tissue inflammation are associated with greater extent of liver fibrosis independent of obesity and SAT fibrosis may contribute to diabetes risk through reduced insulin secretion. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
12. Obstructive Sleep Apnea Syndrome Affects Liver Histology and Inflammatory Cell Activation in Pediatric Nonalcoholic Fatty Liver Disease, Regardless of Obesity/Insulin Resistance.
- Author
-
Nobili, Valerio, Cutrera, Renato, Liccardo, Daniela, Pavone, Martino, Devito, Rita, Giorgio, Valentina, Verrillo, Elisabetta, Baviera, Giuseppe, and Musso, Giovanni
- Published
- 2014
- Full Text
- View/download PDF
13. Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert review.
- Author
-
Liccardo, Daniela, Alisi, Anna, Porta, Gilda, and Nobili, Valerio
- Subjects
ADOLESCENCE ,FATTY liver ,OVERWEIGHT children ,PUBLIC health ,FIBROSIS - Abstract
Evaluation of: Oddy WH, Herbison CE, Jacoby P et al. The western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence. Am. J. Gastroenterol. 108, 778-785 (2013). The prevalence of overweight and obesity in childhood is a major public health concern. According to the obesity trend, the prevalence of pediatric nonalcoholic fatty liver disease (NAFLD) is also increasing. Nonalcoholic fatty liver disease is characterized by a spectrum of hepatic lesions (i.e., steatosis, ballooning, necroinflammation and fibrosis) that can progress to cirrhosis, hepatocellular carcinoma and liver failure with the consequent need for liver transplantation. Pediatric NAFLD is typically of primary origin and it is strongly associated with several features of the metabolic syndrome such as obesity, insulin resistance, dyslipidemia and Type 2 diabetes. The evaluated article reports the prospective relationship between dietary patterns at age 14 years and the presence of NAFLD at age 17 years. A total of 995 adolescents completed a food frequency questionnaire at 14 years and had liver ultrasound at 17 years. Prospective associations between the dietary pattern scores and the risk of NAFLD were analyzed using multiple logistic regression analyses. Nonalcoholic fatty liver disease was present in 15.2% of adolescents. A healthy dietary pattern at 14 years appeared protective against NAFLD at 17 years in centrally obese adolescents. On the contrary, a western dietary pattern at 14 years in this cohort was associated with an increased risk of NAFLD at 17 years, particularly in obese adolescents. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
14. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology.
- Author
-
Della Corte, Claudia, Fintini, Danilo, Giordano, Ugo, Cappa, Marco, Brufani, Claudia, Majo, Fabio, Mennini, Chiara, and Nobili, Valerio
- Subjects
FATTY degeneration ,INSULIN resistance ,FATTY liver ,HYPOLIPOPROTEINEMIA ,FIBROSIS - Abstract
Objective Hepatic steatosis is strongly associated with insulin resistance, but causative mechanisms that link these conditions are still largely unknown. Nowadays, it is difficult to establish whether fatty liver is the cause of insulin resistance or instead the complex metabolic derangements of insulin resistance determine hepatic steatosis and its progression to fibrosis. In patients with familial hypobetalipoproteinemia ( FHBL), hepatic steatosis is because of the genetically determined defective form of apolipoprotein B, independently of metabolic derangements. Therefore patients with FHBL represent a good in vivo model to evaluate the relationships between fatty liver and insulin sensitivity. Methods We evaluated insulin resistance through HOMA- IR in 60 children with echografic and histological features of steatosis; 30 of whom had nonalcoholic fatty liver disease ( NAFLD) and 30 had FHBL. Results All patients had histological features of hepatic steatosis. Patients with FHBL were hypolipidemic, as expected. No significant differences between two groups were observed in liver function tests. IRI and HOMA- IR were statistically higher in NAFLD subjects compared to the FHBL group. Conclusion In our study, we demonstrated that in children with FHBL, hepatic steatosis is dissociated from insulin resistance. This finding suggests that fat accumulation per se may be not a sufficient causal factor leading to insulin resistance, and that other mediators may be involved in the development of alteration in glucose metabolism and metabolic syndrome in patients with NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
15. A 360-degree overview of paediatric NAFLD: Recent insights
- Author
-
Nobili, Valerio, Svegliati-Baroni, Gianluca, Alisi, Anna, Miele, Luca, Valenti, Luca, and Vajro, Pietro
- Subjects
- *
FATTY degeneration , *PEDIATRICS , *FIBROSIS , *JUVENILE diseases , *FATTY liver , *OBESITY , *DIAGNOSIS - Abstract
Summary: Non-alcoholic fatty liver disease (NAFLD) is a multi-faceted disorder, which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with/without fibrosis. The effects of specific risk factors, such as obesity and sedentary lifestyle, on predisposing genetic settings eventually lead to the development of NAFLD in children. The complex interplay between genes and environment in NAFLD pathogenesis is sustained by multiple mechanisms that involve liver crosstalk with other organs and tissues, especially gut and adipose tissue. Unfortunately, natural history of paediatric NAFLD is lacking, and the etiopathogenesis is still in the process of being defined. Potential early predictors and suitable non-invasive diagnostic tools can be discovered based on the pathogenetic mechanisms and histological patterns. This will also help design novel treatments and a comprehensive and successful management strategy for patients. In this review, we discuss the recent advances made in genetics, etiopathogenesis, diagnosis, and therapeutic management of NAFLD, focusing especially on the obesity-related steatotic liver condition. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
16. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
- Author
-
Alkhouri, Naim, Sedki, Emad, Alisi, Anna, Lopez, Rocio, Pinzani, Massimo, Feldstein, Ariel E., and Nobili, Valerio
- Subjects
FATTY liver ,FIBROSIS ,GENETIC markers ,PEDIATRIC diagnosis ,RECEIVER operating characteristic curves - Abstract
Background Nonalcoholic fatty liver disease ( NAFLD) encompasses a spectrum of disease from simple steatosis to steatohepatitis, to fibrosis and cirrhosis. The paediatric NAFLD fibrosis index ( PNFI) and transient elastography ( TE) are potential noninvasive markers for fibrosis. To prospectively evaluate the performance of PNFI and TE in assessing clinically significant fibrosis in children with biopsy-proven NAFLD. Methods Our cohort consisted of 67 consecutive children with biopsy-proven NAFLD. The stage of fibrosis was scored according to the Nonalcoholic Steatohepatitis Clinical Research Network. Fibrosis ≥ 2 was considered clinically significant. PNFI was calculated using age, waist circumference and triglycerides. TE was performed using the Fibroscan apparatus. Results Ten patients had fibrosis stage 2-3 and 57 patients had stage 0-1. Both PNFI and TE values were significantly higher in patients with significant fibrosis ( P < 0.05). The area under the receiver operating characteristic ( ROC) curve for predicting significant fibrosis of PNFI and TE were 0.747 and 1.00 respectively ( P = 0.005). The combined use of PNFI and TE could predict the presence or absence of clinically significant fibrosis in 98% of children with NAFLD. Conclusions In children with NAFLD, the combination of PNFI and TE can be used to accurately assess the presence of clinically significant liver fibrosis. This will help to identify patients who should undergo liver biopsy because the confirmation of advanced fibrosis would lead to closer follow-up and screening for cirrhosis-related complications. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
17. Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments
- Author
-
Alisi, Anna and Nobili, Valerio
- Subjects
- *
INSULIN resistance , *THERAPEUTIC use of vitamin E , *DOCOSAHEXAENOIC acid , *THIAZOLIDINEDIONES , *BEHAVIOR modification , *DIABETES , *DIETARY supplements , *FATTY liver , *HEALTH behavior , *METABOLIC regulation , *WEIGHT loss , *OXIDATIVE stress , *METABOLIC syndrome , *PHYSICAL activity , *CHILDREN , *PREVENTION , *THERAPEUTICS , *DISEASE risk factors - Abstract
Abstract: Over the past decade, non-alcoholic fatty liver disease (NAFLD) has become one of most common chronic liver diseases in children. A greater understanding about the risk factors and molecular pathogenesis of NAFLD suggests that lifestyle interventions aiming to decrease obesity/body mass index and metabolic derangement are the first line of treatments adopted in children affected by this disease. However, because these therapeutic options are often at the beginning misjudged by the patients and their parents, the use of pharmacologic agents may help to protect the liver and other organs from further irreversible tissue damage. Pharmacologic therapies against one or more specific factors and/or molecules involved in the development of NAFLD (i.e., insulin resistance, free fatty acid lipid toxicity, and oxidative stress) also might slow the progression of this increasingly prevalent pediatric disorder. On this basis, insulin sensitizers, antioxidants, cytoprotective agents, and dietary supplementations have been evaluated in pediatric clinical trials. In this review, we discuss the efficacy of the dietary approaches, possibly coupled with regular exercise, on decreasing the metabolic and histologic damage in pediatric NAFLD. We also emphasize several advantages of the pharmacologic treatments adopted or adoptable in combination with lifestyle interventions in children with NAFLD. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
18. Liver fibrosis in paediatric liver diseases.
- Author
-
Alisi, Anna, de Vito, Rita, Monti, Lidia, and Nobili, Valerio
- Subjects
FIBROSIS ,PEDIATRICS ,LIVER biopsy ,CIRRHOSIS of the liver ,DISEASE progression ,HISTOPATHOLOGY - Abstract
Numerous paediatric liver diseases from different origins may be complicated by development of liver fibrosis and progression to cirrhosis. Although fibrogenesis, which represents a major driving force for the development of liver fibrosis, has common tracts whatever the aetiology, liver fibrosis has different histopathological patterns in paediatric liver disease. In these diseases management choices may depend upon the stage of liver fibrosis. Thus, the accurate estimation of histological pattern of liver fibrosis is important for the prevention of the subsequent complications. Liver biopsy has long been considered as a gold standard diagnostic method for assessing liver fibrosis. However, due to its several disadvantages, in the last decades alternative and accurate non-invasive means to estimate fibrosis are developed. In this review, we characterised the most frequent histological patterns of liver fibrosis in paediatric liver diseases. Furthermore, we describe use of liver biopsy in diagnosis and staging of liver fibrosis, list the alternative non-invasive techniques that have an emerging role in the assessment of liver fibrosis, and propose a management algorithm. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
19. Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease.
- Author
-
Alisi, Anna, Bedogni, Giorgio, De Vito, Rita, Comparcola, Donatella, Manco, Melania, and Nobili, Valerio
- Subjects
FATTY liver ,INFLAMMATION ,CHRONIC diseases ,JUVENILE diseases ,FIBROSIS ,BIOPSY ,DISEASES in teenagers - Abstract
Abstract: Background: The non-alcoholic steato-hepatitis Clinical Research Network has recently shown that portal chronic inflammation is associated with liver fibrosis in American children with non-alcoholic fatty liver disease. Aim: We tested whether the portal chronic inflammation-fibrosis association was present in a series of Italian children with non-alcoholic fatty liver disease. Methods: We re-assessed the liver biopsies of 144 consecutive Italian children with non-alcoholic fatty liver disease aged 3–18 years and followed at the “Bambino Gesù” Paediatric Hospital. Non-alcoholic fatty liver disease and portal chronic inflammation were diagnosed using the non-alcoholic steato-hepatitis Clinical Research Network criteria. Anthropometry, body composition, liver enzymes, metabolic parameters and blood pressure were measured in all children. Results: Two children had no portal chronic inflammation, 84 had mild and 58 more than mild portal chronic inflammation according to the non-alcoholic steato-hepatitis Clinical Research Network criteria. Children with no or mild portal chronic inflammation had the same clinical features of those with more than mild portal chronic inflammation except for insulin resistance, which was greater. There was no association between steatosis, lobular inflammation, ballooning, fibrosis and portal chronic inflammation. Conclusion: We were not able to confirm the existence of a clinico-pathological association between portal chronic inflammation and disease severity in a series of Italian children with non-alcoholic fatty liver disease. Some clinico-pathological correlates of paediatric non-alcoholic fatty liver disease may be population-specific. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
20. Steatosis and fibrosis in paediatric liver transplant: Insidious graft’s enemies – A call for clinical studies and research.
- Author
-
Nobili, Valerio, Candusso, Manila, Torre, Giuliano, and de Ville de Goyet, Jean
- Subjects
- *
FATTY degeneration , *FIBROSIS , *PEDIATRICS , *HEPATITIS C - Abstract
The article reflects on steatosis and fibrosis in paediatric liver transplant. It is said that post-transplant complications are the development of steatosis and fibrosis, which are observed in patients with recurrent hepatitis C infection. It is said that the pathogenesis of steatosis and fibrosis may influence the graft response to the new and different environment.
- Published
- 2010
- Full Text
- View/download PDF
21. The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease.
- Author
-
Nobili, Valerio, Alisi, Anna, Vania, Andrea, Tiribelli, Claudio, Pietrobattista, Andrea, and Bedogni, Giorgio
- Subjects
- *
LIVER diseases , *FIBROSIS , *JUVENILE diseases , *PEDIATRICS , *MEDICAL sciences - Abstract
Background: Liver fibrosis is a stage of non-alcoholic fatty liver disease (NAFLD) which is responsible for liver-related morbidity and mortality in adults. Accordingly, the search for noninvasive markers of liver fibrosis has been the subject of intensive efforts in adults with NAFLD. Here, we developed a simple algorithm for the prediction of liver fibrosis in children with NAFLD followed at a tertiary care center. Methods: The study included 136 male and 67 female children with NAFLD aged 3.3 to 18.0 years; 141 (69%) of them had fibrosis at liver biopsy. On the basis of biological plausibility, readily availability and evidence from adult studies, we evaluated the following potential predictors of liver fibrosis at bootstrapped stepwise logistic regression: gender, age, body mass index, waist circumference, alanine transaminase, aspartate transaminase, gamma-glutamyl-transferase, albumin, prothrombin time, glucose, insulin, triglycerides and cholesterol. A final model was developed using bootstrapped logistic regression with bias-correction. We used this model to develop the 'pediatric NAFLD fibrosis index' (PNFI), which varies between 0 and 10. Results: The final model was based on age, waist circumference and triglycerides and had a area under the receiver operating characteristic curve of 0.85 (95% bootstrapped confidence interval (CI) with bias correction 0.80 to 0.90) for the prediction of liver fibrosis. A PNFI ≥ 9 (positive likelihood ratio = 28.6, 95% CI 4.0 to 201.0; positive predictive value = 98.5, 95% CI 91.8 to 100.0) could be used to rule in liver fibrosis without performing liver biopsy. Conclusion: PNFI may help clinicians to predict liver fibrosis in children with NAFLD, but external validation is needed before it can be employed for this purpose. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
22. Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease.
- Author
-
Nobili, Valerio, Parkes, Julie, Bottazzo, Gianfranco, Marcellini, Matilde, Cross, Richard, Newman, Daniel, Vizzutti, Francesco, Pinzani, Massimo, and Rosenberg, William M.
- Subjects
BIOMARKERS ,FATTY liver ,FIBROSIS ,LIVER biopsy ,MONOCLONAL antibodies ,BODY mass index ,JUVENILE diseases ,DEVELOPED countries - Abstract
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease in children and adolescents in industrialized countries. It is important to accurately determine the stage of fibrosis in these patients. The enhanced liver fibrosis (ELF) test has been validated for staging liver fibrosis in adult patients with chronic liver diseases, including NAFLD. We investigated the performance of this test in assessing liver fibrosis in children and adolescents with NAFLD, identified by biopsy. Methods: The ELF test was performed on a panel of serum samples collected from 112 consecutive subjects that were likely to have NAFLD (64 male, mean age of 13.8 ± 3.3). A previously described and validated algorithm was used to analyze the data on hyaluronic acid (HA), amino-terminal propeptide of type III collagen (PIIINP), and tissue inhibitor of metalloproteinase 1 (TIMP-1) levels. Results: In pediatric patients with NAFLD, the ELF test predicted liver fibrosis stage with a high degree of sensitivity and specificity; results were superior to those reported for adults. The area under receiver operating characteristic curves/best possible ELF test cut-off values for the prediction of “any” (≥stage 1), moderate-perisinusoidal (≥stage 1b), moderate-portal/periportal (≥stage 1c), significant (≥stage 2), or advanced (≥stage 3) fibrosis were 0.92/9.28, 0.92/9.33, 0.90/9.54, 0.98/10.18 and 0.99/10.51, respectively. Conclusions: The ELF test can be used to accurately assess the level of liver fibrosis in pediatric patients with NAFLD. This information is important for identifying patients with progressive fibrosis that require further histopathological analysis or therapeutic follow-up. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
23. Vitamin D and liver fibrosis: let's start soon before it's too late.
- Author
-
Nobili, Valerio and Reif, Shimon
- Subjects
- *
VITAMIN D , *FIBROSIS , *LIVER cells , *EXTRACELLULAR matrix , *PROTEINS - Abstract
In this article, the author offers views on the treatment of Vitamin D and liver fibrosis. He mentions that liver fibrosis is a reversible wound-healing response caused by the hepatic stellate cell (HSC)-mediated excessive accumulation of extracellular matrix proteins. He also mentions that demonstration of the antifibrotic effect of Vitamin D in liver fibrosis providing additional support to previous pivotal studies.
- Published
- 2015
- Full Text
- View/download PDF
24. A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis.
- Author
-
Alkhouri, Naim, Carter–Kent, Christine, Lopez, Rocio, Rosenberg, William M., Pinzani, Massimo, Bedogni, Giorgio, Feldstein, Ariel E., and Nobili, Valerio
- Subjects
LIVER diseases ,FATTY liver ,FIBROSIS ,NONINVASIVE diagnostic tests ,JUVENILE diseases ,FATTY degeneration ,CIRRHOSIS of the liver ,BODY mass index ,BLOOD pressure ,TRIGLYCERIDES - Abstract
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) encompasses diseases from simple steatosis, to steatohepatitis, to fibrosis, and cirrhosis. The pediatric NAFLD fibrosis index (PNFI) and the enhanced liver fibrosis (ELF) test are potential noninvasive markers for fibrosis. We prospectively evaluated the performance of PNFI and ELF in assessing fibrosis in children with biopsy-proven NAFLD. Methods: We analyzed 111 consecutive children with NAFLD. The stage of fibrosis was scored according to the Nonalcoholic Steatohepatitis Clinical Research Network. PNFI was calculated based on age, waist circumference, and levels of triglycerides. The ELF test was used to determine levels of hyaluronic acid, the amino-terminal propeptide of type III collagen, and tissue inhibitor of metalloproteinase-1. Results: Some degree of fibrosis was detected in 68.5% of patients (62 had stage 1, 5 had stage 2, and 9 had stage 3). PNFI and ELF test values was higher among patients with fibrosis (P < .001). The area under the receiver operating characteristic (ROC) curve for predicting fibrosis using the PNFI and ELF test was 0.761 and 0.924, respectively. The best performance was obtained by combining PNFI and ELF test with (area under the receiver operating characteristic curve = 0.944). The combined results from the PNFI and ELF test predicted the presence or absence of fibrosis in 86.4% of children with NAFLD. Conclusions: In children with NAFLD, the combined results from the PNFI and ELF test can accurately assess the presence of liver fibrosis and identify patients that should be evaluated by liver biopsy. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
25. Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?
- Author
-
Corte, Claudia Della, Alisi, Anna, and Nobili, Valerio
- Subjects
- *
LIVER disease diagnosis , *FIBROSIS , *ASPARTATE aminotransferase , *BLOOD platelets , *LIVER diseases , *DIAGNOSIS , *DISEASE risk factors - Abstract
A letter to the editor is presented in response to the article "Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio (APRI): Usefulness in patients with chronic liver disease," by Y. Yilmaz and colleagues in the 2011 issue.
- Published
- 2011
26. Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease
- Author
-
Alkhouri, Naim, De Vito, Rita, Alisi, Anna, Yerian, Lisa, Lopez, Rocio, Feldstein, Ariel E., and Nobili, Valerio
- Subjects
- *
FATTY liver , *CLINICAL trials , *JUVENILE diseases , *INFLAMMATION , *HISTOPATHOLOGY , *FATTY degeneration , *FIBROSIS , *TRIGLYCERIDES , *DIAGNOSIS - Abstract
Background & Aims: Pediatric non-alcoholic fatty liver disease (NAFLD) may present with a distinct histopathological pattern characterized by the presence of predominant portal-based injury and portal inflammation (PI). We aimed at developing a new grading score for pediatric NAFLD to be used in clinical trials that takes into account the presence of PI and the weight of histological features. Methods: Our training set consisted of 203 children with biopsy-proven NAFLD. The diagnosis of non-alcoholic steatohepatitis (NASH) was based on Brunt’s criteria. Histological features were scored: steatosis (0–3), lobular inflammation (0–3), ballooning (0–2), and PI (0–2). Logistic regression analysis was performed to apply weight to each feature. The new score was called the Pediatric NAFLD Histological Score or PNHS. The validation set consisted of 100 children with NAFLD. Results: The mean age of the initial cohort was 12.4±3.4years and significant fibrosis (fibrosis stage ⩾2) was present in 26 patients (12.8%). NASH was diagnosed in 135 patients with a mean NAS of 4.5±1.4. The mean PNHS in the NASH group was 89±20.5 compared to 21.9±24.5 in the “not NASH” group, p <0.001. PNHS correlated with the presence of NASH according to the pathologist’s diagnosis, better than the NAFLD activity score (NAS), p =0.011. The area under the ROC curve (AUC) for the diagnosis of NASH was 0.96 for PNHS. Similar findings were observed in the validation set with an AUC of 0.94. Conclusions: PNHS may be used for histological grading of pediatric NAFLD with excellent correlation with the presence of NASH. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.